XML 37 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated statements of comprehensive loss - EUR (€)
€ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Consolidated statements of comprehensive loss      
Revenue € 128,381 € 48,780 € 40,478
Cost of sales 86,378 26,005 19,941
Gross profit 42,003 22,775 20,537
Research and development expenses 14,935 9,590 6,300
General administrative expenses 37,665 23,160 18,610
Selling expenses 7,580 9,254 7,474
Impairment of financial assets 3,738 752 792
Other operating income 2,394 3,781 2,306
Other operating expenses 182 1,284 273
Real estate transfer tax expenses   1,200 0
Operating loss (19,703) (18,684) (10,606)
Interest and similar income 6 16 33
Interest and similar expenses 1,400 2,029 1,075
Financial costs, net (1,394) (2,013) (1,042)
Loss before taxes (21,097) (20,697) (11,648)
Income taxes expenses/(benefits) 281 158 (310)
Loss for the year (21,378) (20,855) (11,338)
Other comprehensive income, all attributable to equity holders of the parent (48) 16 (8)
Total comprehensive loss (21,426) (20,839) (11,346)
Attributable to:      
Equity holders of the parent (21,486) (20,658) (10,971)
Non‑controlling interests 60 (181) (375)
Total comprehensive loss € (21,426) € (20,839) € (11,346)
Loss per share - Basic and diluted € (1.02) € (1.27) € (0.8)